Percutaneous Coronary Intervention for Chronic Total Occlusion-Contemporary Approach and Future Directions

Emil Julian Dąbrowski1, Michał Święczkowski1, Joanna Maria Dudzik2

  • 1Department of Invasive Cardiology, Medical University of Bialystok, 24A Sklodowskiej-Curie St., 15-276 Bialystok, Poland.

PubMed

Insights

Percutaneous coronary intervention for coronary chronic total occlusion (CTO) is increasing, but long-term benefits remain uncertain. This review summarizes the latest evidence on CTO recanalization, aiding invasive cardiologists in treatment decisions.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Coronary chronic total occlusion (CTO) presents a growing challenge in aging populations.
  • Percutaneous coronary interventions (PCI) for CTO are increasing despite limited guideline indications.
  • Recent randomized clinical trials and observational studies have advanced understanding of CTO interventions.

Purpose of the Study:

  • To provide a comprehensive review of the latest evidence on percutaneous recanalization of coronary artery chronic total occlusion.
  • To address uncertainties regarding the rationale and long-term benefits of CTO revascularization.
  • To support invasive cardiologists in managing complex CTO cases.

Main Methods:

  • Systematic literature review of recent randomized clinical trials and large observational studies.
  • Analysis of evidence on percutaneous coronary intervention (PCI) for coronary chronic total occlusion (CTO).
  • Synthesis of data on revascularization rationale and long-term outcomes in CTO patients.

Main Results:

  • Significant progress has been made in addressing knowledge gaps in CTO interventions.
  • Evidence regarding the long-term benefits and optimal rationale for CTO revascularization remains inconclusive.
  • The review consolidates current understanding of percutaneous CTO recanalization techniques and outcomes.

Conclusions:

  • The optimal strategy for coronary chronic total occlusion (CTO) revascularization requires further investigation.
  • Invasive cardiologists face increasing rates of CTO PCI with evolving evidence.
  • A comprehensive understanding of the latest evidence is crucial for informed decision-making in CTO management.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
13
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
11
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
13
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
22
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
33
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
11